Reducing swelling and relieving pain

"Reducing swelling and relieving pain" is a clinical therapeutic indication or pharmacological action rather than a specific biological target, molecule, or receptor. This dual effect involves the reduction of inflammatory edema (detumescence) and the mitigation of nociception (analgesia). In clinical practice, this outcome is typically achieved by drugs that target the arachidonic acid cascade, most notably inhibitors of the cyclooxygenase (COX) enzymes, which prevent the formation of prostaglandins that mediate both vascular permeability and pain sensitivity [14, 15]. It is a foundational goal in the management of acute injuries, post-operative recovery, and chronic inflammatory diseases like rheumatoid arthritis [1, 14]. In the context of traditional medicine, such as Traditional Chinese Medicine (TCM), the term refers to the functional classification of herbs and treatments (e.g., Si-Miao Pill or cold therapy) that promote recovery by resolving inflammation and alleviating physical discomfort [2, 11, 15]. Because it describes a physiological result rather than a single molecular entity, it is not considered a valid therapeutic target in drug discovery nomenclature [14].

Other names

Anti-inflammatory and analgesic effectDetumescence and analgesiaXiāozhǒng zhǐtòngSwelling reduction and pain relief

Inhibition of cyclooxygenase enzymes (COX-1 and COX-2) to reduce prostaglandin synthesis, suppression of pro-inflammatory cytokines (e.g., TNF-alpha, IL-6), and modulation of nociceptive pathways to block pain signal transmission.